Drug Company Whistleblower Exposes Serious Problems at Plant that Makes Generics
November 6, 2013
A drug company whistleblower who exposed serious problems at the company that makes popular drugs used in the United States is telling his story to CBS News. Kinesh Thakur worked for major, drug manufacturer Ranbaxy which made generic versions of drugs like Lipitor and antibiotics at plants in India. He revealed disturbing problems with data the company was required to provide to the FDA to show the effectiveness of the drugs it produced. It’s a cautionary tale for all Americans, particularly when you consider that 80-percent of all drugs prescribed in the U.S. are generics. Click here to watch this report by CBS News Correspondent John Miller.
Click on the video below to watch a second report by John Miller which aired on CBS This Morning.
- Can You Trust Generic Drugs?
- Are Cholesterol Lowering Drugs Safe for Healthy People?
- Over-prescribing Anti-psychotic Drugs for Kids
- Consumer Hero vs. Big Pharma – Who Wins?
- Warning: Generic Drugs Not Always Equivalent to Name Brands
- Does Your Doctor Get Money from Drug Companies?
- 5 Ways Drug Companies Put Profits Before Patients
- Drug Ads on TV Are Bad For Your Health